An Evaluation of the Proposed PMPRB Amendments is a new study that finds Ottawa's amendments to the Patented Medicines Regulations and subsequent drug-pricing changes may result in lower costs, but will also likely reduce Canadians’ access to life-saving pharmaceuticals and potentially discourage investment in Canada’s pharmaceutical sector.

Understanding Universal Health Care Reform Options: Cost-Sharing for Patients is a new study that finds Canada is only one of six (out of 28) industrialized countries with universal health-care that doesn't use any form of cost-sharing as part of the model, which can be used to incentivize more efficient use of scare health resources and potentially reduce wait times.